A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients

International Journal of Oncology

Volumn 30, Issue 2, 2007, Pages 421-428

  Kurehara, Hiroki ^a   Ishiguro, Hideyuki ^a   Kimura, Masahiro ^a   Mitsui, Akira ^a   Ando, Takuya ^a   Sugito, Nobuyoshi ^a   Mori, Ryota ^a   Takashima, Nobuhiro ^a   Ogawa, Ryo ^a   Fujii, Yoshitaka ^a   Kuwabara, Yoshiyuki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Post operative survival; Quantitative reverse transcription polymerase chain reaction; RSRC2 (arginine serine rich coiled coil 2)

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RSRC2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RNA INTERFERENCE; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

AGED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEINS;

EID: 34047246679     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dawsey SM, Wang GQ, Weinstein WM, Lewin KJ, Liu FS, Wiggett S, Nieberg RK, Li JY and Taylor PR: Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology 105: 1333-1340, 1993.
2. Kakizoe T, Yamaguchi N and Mitsuhashi F: Cancer incidence in Japan, 2001. The editorial board of Cancer Statistics in Japan. Tokyo: Foundation for Promotion of Cancer Research, 2001.
3. Shiozaki H, Doki Y, Kawanishi K, Shamma A, Yano M, Inoue M and Monden M: Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surgery 127: 552-561, 2000.
4. Faivre J, Forman D, Esteve J and Gatta G: Survival of patients with esophageal and gastric cancers in Europe. Eur J Cancer 34: 2167-2175, 1998. (Pubitemid 29036882)
5. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE and Wilcox CM: Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95: 1434-1443, 2002.
6. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin 51: 15-36, 2001.
7. Lightdale CJ: Esophageal cancer. American College of Gastroenterology. Am J Gastroenterol 94: 20-29, 1999.
8. Sobin L and Wittekind C (eds): TNM Classification of Malignant Tumors. 6th edition. Wiley-Liss, New York, pp60-64, 2002.
9. Robert V, Michel P, Flaman JM, Chiron A, Martin C, Charbonnier F, Paillot B and Frebourg T: High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 21: 563-565, 2000.
10. Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, Suzuki Y, Chan T, Hannon GJ, Mergner WJ and Abraham JM: Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Hum Mol Genet 4: 1883-1887, 1995.
11. Nishiwaki T, Daigo Y, Kawasoe T and Nakamura Y: Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer 27: 169-176, 2000.
12. Miyake S, Nagai K, Yoshino K, Oto M, Endo M and Yuasa Y: Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54: 3007-3010, 1994.
13. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E and Nakamura Y: Molecular cloning of a candidate tumor suppressor gene DLC1, from chromosome 3p21.3. Cancer Res 59: 1966-1972, 1999.
14. Kitamura A, Yashima K, Okamoto E, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Kaibara N and Kawasaki H: Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis. Oncology 61: 205-211, 2001.
15. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H: Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933, 2002.
16. Kawabe A, Shimada Y, Uchida S, Maeda M, Sato F, Itami A and Imamura M: Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 62: 46-54, 2002.
17. Hu YC, Lam KY, Law S, Wong J and Srivastava G: Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 7: 3519-3525, 2001.
18. Park JS, Young Yoon S, Kim JM, Yeom YI, Kim YS and Kim NS: Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray. Cancer Lett 214: 19-33, 2004.
19. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of surviving in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95, 2001.
20. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Ishiguro H, Kudo J, Terashita Y, Konishi S and Fujii Y: Expression of PTTG (Pituitary Tumor Transforming Gene) in esophageal cancer. Jpn J Clin Oncol 32: 233-237, 2002.
21. Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y, Kudo J, Konishi S, Kato J, Koyama H, Kimura M, Sato A, Shinoda N, Kuwabara Y and Fujii Y: Decreased Peroxisome Proliferator-activated Receptor Gamma Gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32: 238-243, 2002. (Pubitemid 43102806)
22. Konishi S, Ishiguro H, Shibata Y, Kudo J, Terashita Y, Sugiura H, Koyama H, Kimura M, Sato A, Shinoda N, Kuwabara Y and Fujii Y: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer 95: 2473-2478, 2002.
23. Terashita Y, Ishiguro H, Haruki N, Sugiura H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y and Fujii Y: Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep 12: 827-831, 2004.
24. Takashima N, Ishiguro H, Kuwabara Y, Kimura M, Haruki N, Ando T, Kurehara H, Sugito N, Mori R and Fujii Y: Expression and prognostic roles of PABPC1 in esophageal cancer: Correlation with tumor progression and postoperative survival. Oncol Rep 15: 667-671, 2006.